Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

Dowsing B, Dehbi HM, Andres MS, Chung R, Oashou A, Wilson JM, Hussein I, Meredith B, Pierce I, Ahmed S, Pedra J, Worn O, Howe M, Assadullah S, Schmid P, Roylance R, Crake T, Westwood M, Ghosh AK, Auger D, Plymen CM, Baksi J, Nazir MS, Moon JC, Chen D, Lyon AR, Walker JM, Manisty CH.

Open source

DOI: 10.1093/eurheartj/ehag707
Published: 2026-08-30
Container: Eur Heart J
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehag707,
  title = {Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.},
  author = {Dowsing B and  Dehbi HM and  Andres MS and  Chung R and  Oashou A and  Wilson JM and  Hussein I and  Meredith B and  Pierce I and  Ahmed S and  Pedra J and  Worn O and  Howe M and  Assadullah S and  Schmid P and  Roylance R and  Crake T and  Westwood M and  Ghosh AK and  Auger D and  Plymen CM and  Baksi J and  Nazir MS and  Moon JC and  Chen D and  Lyon AR and  Walker JM and  Manisty CH.},
  year = {2026},
  journal = {Eur Heart J},
  doi = {10.1093/eurheartj/ehag707},
  url = {https://doi.org/10.1093/eurheartj/ehag707}
}

RIS

TY  - JOUR
TI  - Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.
AU  - Dowsing B
AU  -  Dehbi HM
AU  -  Andres MS
AU  -  Chung R
AU  -  Oashou A
AU  -  Wilson JM
AU  -  Hussein I
AU  -  Meredith B
AU  -  Pierce I
AU  -  Ahmed S
AU  -  Pedra J
AU  -  Worn O
AU  -  Howe M
AU  -  Assadullah S
AU  -  Schmid P
AU  -  Roylance R
AU  -  Crake T
AU  -  Westwood M
AU  -  Ghosh AK
AU  -  Auger D
AU  -  Plymen CM
AU  -  Baksi J
AU  -  Nazir MS
AU  -  Moon JC
AU  -  Chen D
AU  -  Lyon AR
AU  -  Walker JM
AU  -  Manisty CH.
PY  - 2026
JO  - Eur Heart J
DO  - 10.1093/eurheartj/ehag707
UR  - https://doi.org/10.1093/eurheartj/ehag707
ER  -

APA

B, D., HM, D., MS, A., R, C., A, O., JM, W., I, H., B, M., I, P., S, A., J, P., O, W., M, H., S, A., P, S., R, R., T, C., M, W., AK, G., D, A., CM, P., J, B., MS, N., JC, M., D, C., AR, L., JM, W., & CH., M. (2026). Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.. Eur Heart J. https://doi.org/10.1093/eurheartj/ehag707

Source records

europe-pmc · retrieved 2026-09-25T19:36:52.113Z